PLx Pharma Inc. Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Award Notice, by and between PLx Pharma Inc. and Rita OConnor, dated February 13, 2023 (Filed With SEC on February 13, 2023)
- Award Notice, by and between PLx Pharma Inc. and Natasha Giordano, dated February 13, 2023 (Filed With SEC on February 13, 2023)
- Description of Registered Securities (Filed With SEC on March 11, 2022)
- Description of Registered Securities (Filed With SEC on March 12, 2021)
- Description of Registered Securities (Filed With SEC on March 13, 2020)
- AMENDMENT NUMBER ONE TO AGREEMENT (Filed With SEC on August 15, 2017)
- AMENDMENT NUMBER TWO TO AGREEMENT (Filed With SEC on June 12, 2017)
- AMENDMENT NUMBER ONE TO AGREEMENT (Filed With SEC on June 12, 2017)
- LOCK-UP AGREEMENT (Filed With SEC on December 22, 2016)
- LOCK-UP AGREEMENT (Filed With SEC on December 22, 2016)
- AMENDMENT NUMBER TWO TO AGREEMENT (Filed With SEC on January 5, 2016)
- AMENDED AND RESTATED PATENT LICENSEAGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITYOF TEXAS SYSTEM AND PLX PHARMA INC. DATED December11, 2009 (Filed With SEC on January 5, 2016)
- AMENDMENT NUMBER TWO TO AGREEMENT (Filed With SEC on October 5, 2015)
- AMENDMENT NUMBER ONE TO AGREEMENT (Filed With SEC on October 5, 2015)
- AMENDED AND RESTATED PATENT LICENSEAGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITYOF TEXAS SYSTEM AND PLX PHARMA INC. DATED December11, 2009 (Filed With SEC on October 5, 2015)
- NDA Regulatory Activities Scope of Services (May 2014 August 2014) (Filed With SEC on May 29, 2014)
- AGREEMENT (Filed With SEC on February 6, 2014)
- Quality Agreement Dated as of September 3rd,2013 (the EFFECTIVE Date) By and Between PolyPeptide Laboratories San Diego (PPL-SD) And Dipexium Pharmaceuticals (Dipexium) (Filed With SEC on February 6, 2014)
